title: Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy.
authors: Department of Pathology, The University of Chicago, Chicago, IL, USA.
authors: Leticia
authors: L
authors: Corrales
authors: Department of Pathology, The University of Chicago, Chicago, IL, USA; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA. Electronic address: tgajewsk@medicine.bsd.uchicago.edu.
authors: Thomas F
authors: TF
authors: Gajewski
mesh_terms: D056704:Adaptive Immunity / Q000276:immunology; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D007167:Immunotherapy / Q000379:methods*; D008565:Membrane Proteins / Q000276:immunology* / Q000378:metabolism; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D015398:Signal Transduction / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D059016:Tumor Microenvironment / Q000276:immunology; D000099197:STING Protein
chemical_list: D008565:Membrane Proteins; C532857:STING1 protein, human; D000099197:STING Protein
keywords: STING pathway; Tumor immunology; Type I IFN